40
Participants
Start Date
November 30, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Citalopram
Participants will be commenced on Citalopram 20mgs daily. At week 4 participants will be assessed for response to treatment . If no response, dose of Citalopram will be increased to 40mgs for the remaining 8 weeks of the study. Patients who respond will remain on 20mgs for remaining 8 weeks.
Placebo
Participants in the control group will receive a matched placebo. At week 4 participants will be assessed for response to treatment. If no response, dose of placebo will be increased to 40mgs for the remaining 8 weeks of the study. Patients who respond will remain on 20mgs for remaining 8 weeks.
RECRUITING
Regional Respiratory Centre, Belfast City Hospital, Belfast
Collaborators (1)
Asthma UK
OTHER
Liam Heaney
OTHER